Loading...

Improving Combination Osteoporosis Therapy in a Preclinical Model of Heightened Osteoanabolism

Combining anticatabolic agents with parathyroid hormone (PTH) to enhance bone mass has yielded mixed results in osteoporosis patients. Toward the goal of enhancing the efficacy of these regimens, we tested their utility in combination with loss of the transcription factor Nmp4 because disabling this...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Endocrinology
Main Authors: Shao, Yu, Hernandez-Buquer, Selene, Childress, Paul, Stayrook, Keith R., Alvarez, Marta B., Davis, Hannah, Plotkin, Lilian I., He, Yongzheng, Condon, Keith W., Burr, David B., Warden, Stuart J., Robling, Alexander G., Yang, Feng-Chun, Wek, Ronald C., Allen, Matthew R., Bidwell, Joseph P.
Format: Artigo
Sprog:Inglês
Udgivet: Endocrine Society 2017
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5659666/
https://ncbi.nlm.nih.gov/pubmed/28637206
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/en.2017-00355
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!